Division for Cardiovascular Pharmacology Mid-Career Award honors mid-career independent investigators for scientific achievement and contributions to cardiovascular science, including vascular pharmacology.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2028 (Nomination deadline, projected)
Funding Amounts: Achievement recognition
Summary: Recognizes mid-career independent investigators for contributions to cardiovascular science, including vascular pharmacology.
Key Information: Nominees must be primary members of ASPET’s Division for Cardiovascular Pharmacology.
The Division for Cardiovascular Pharmacology Mid-Career Award is an achievement award administered by the American Society for Pharmacology and Experimental Therapeutics (ASPET) through its Division for Cardiovascular Pharmacology. It recognizes and honors mid-career independent investigators working in any area of cardiovascular science. ASPET’s awards overview identifies vascular pharmacology as the award’s specialty, while the division-sponsored awards description states the broader cardiovascular science scope.
Presented biennially, the award forms part of ASPET’s division-sponsored awards, which recognize excellence and contributions in specific areas of pharmacology. It recognizes scientific achievement rather than supporting a proposed research project. Eligible investigators may work in academia, industry, or private or government institutes.